Simultaneous percutaneous microwave ablation and biopsy for highly suspected malignant pulmonary nodules: a retrospective cohort study.

BACKGROUND

The conventional diagnosis and treatment for highly suspected malignant pulmonary nodules (PNs) can avoid unnecessary treatment to some extent. However, the relatively separate puncture processes may not only increase puncture-related complications, but also increase the patient's radiation exposure and hospitalization costs. The purpose of this study was to retrospectively analyze the effectiveness of simultaneous percutaneous microwave ablation (MWA) and percutaneous biopsy (PB) for PNs.

METHODS

From August 2015 to August 2022, 65 consecutive patients [48 solid nodules, 6 ground glass opacities (GGOs), 11 mixed nodules] with suspected single malignant PN underwent MWA and PB combination treatments at the First Affiliated Hospital of Zhengzhou University. The total of 30 patients in Group A underwent synchronous PB and MWA (strategy: low-power MWA-PB-high-power MWA), whereas 35 patients in Group B underwent asynchronous PB and MWA. The technical success, complete ablation (CA), complications, total procedure time (TPT), patient exposure dose (PED), hospitalization time, and costs were compared. An independent samples , χ, or Fisher's exact tests were used.

RESULTS

The technical success (100% 100%) and CA (100% 97.1%) rates were not significantly different between Groups A and B. The complications of intrapulmonary hemorrhage (16.7% 41.4%, P=0.02) and hemoptysis (0% 8.6%, P=0.04) were significantly different between Groups A and B. TPT (41.6±7.9 57.3±8.8 min, P<0.001), PED (12.9±1.4 19.4±2.3 mSv, P<0.001), hospitalization stay (4.7±1.3 9.1±2.1 days, P<0.001) and costs (3,768.8±652.9 4,508.0±514.1 USD, P<0.001) also showed significant differences between Groups A and B.

CONCLUSIONS

Synchronous PB and MWA for PNs is a safe and effective strategy that can decrease bleeding, PED, the hospitalization stay, and costs.